Back to search results

Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

Abroad (travel likely)RecruitingPHASE2

Conditions

Mycosis Fungoides

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Bouthaina Dabaja, MD) · bdabaja@mdanderson.org · 713-563-2406
    Contact: Principal Investigator (Bouthaina Dabaja, MD)
Study leads

  • Bouthaina Dabaja, MD

    Principal Investigator

    M.D. Anderson Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)